Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.63 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.56 |
| ▸ | KCNJ1 | P48048 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | LPL | P06858 | 1/20 | 0.45 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | MGLL | Q99685 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | DAO | P14920 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10568237 | 0.94 | HSD17B10 (0.73) | CYP2A6TSHRHSD17B10LOXL2KCNJ1 | |
| SCHEMBL2041798 | 0.94 | TSHR (0.73) | CYP2A6TSHRHSD17B10LOXL2KCNJ1 | |
| SCHEMBL10456965 | 0.94 | TSHR (0.73) | CYP2A6TSHRHSD17B10LOXL2KCNJ1 | |
| SCHEMBL9317548 | 0.92 | TSHR (0.71) | CYP2A6TSHRHSD17B10LOXL2KCNJ1 | |
| SCHEMBL10567320 | 0.92 | HSD17B10 (0.77) | CYP2A6TSHRHSD17B10LOXL2KCNJ1 | |
| SCHEMBL8379783 | 0.92 | TSHR (0.71) | CYP2A6TSHRHSD17B10LOXL2KCNJ1 | |
| SCHEMBL25188141 | 0.88 | CYP2A6 (0.70) | CYP2A6TSHRHSD17B10LOXL2KCNJ1 | |
| SCHEMBL921444 | 0.88 | CYP2A6 (0.53) | CYP2A6TSHRHSD17B10LOXL2KCNJ1 | |
| SCHEMBL7982533 | 0.87 | CYP2A6 (0.52) | CYP2A6TSHRHSD17B10LOXL2KCNJ1 | |
| SCHEMBL13311496 | 0.87 | CYP2A6 (0.52) | CYP2A6TSHRHSD17B10LOXL2KCNJ1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12534685-B2 | Fragrance composition | SYMRISE AG (DE) | 2026-01-27 | — | — | US | claimed |
| US-20230159854-A1 | A FRAGRANCE COMPOSITION | SYMRISE AG (DE) | 2023-05-25 | — | — | US | claimed |
| EP-4149919-A1 | A FRAGRANCE COMPOSITION | Symrise AG (DE) | 2023-03-22 | — | — | EP | claimed |
| CN-115551828-A | Perfume composition | 西姆莱斯股份公司 | 2022-12-30 | — | — | CN | claimed |
| WO-2021228840-A1 | A FRAGRANCE COMPOSITION | SYMRISE AG (DE) | 2021-11-18 | — | — | WO | claimed |
| WO-2021228352-A1 | A FRAGRANCE COMPOSITION | SYMRISE AG (DE) | 2021-11-18 | — | — | WO | claimed |
| EP-2770005-B1 | EPOXY RESIN COMPOSITION AND HIGH FREQUENCY ELECTRONIC-CIRCUIT SUBSTRATE MANUFACTURED BY USING THE SAME | GUANGDONG SHENGYI SCI TECH CO (CN) | 2019-05-08 | — | — | EP | claimed |
| EP-2770005-A1 | EPOXY RESIN COMPOSITION AND HIGH FREQUENCY ELECTRONIC-CIRCUIT SUBSTRATE MANUFACTURED BY USING THE SAME | Guangdong Shengyi Sci. Tech Co., Ltd (CN) | 2014-08-27 | — | — | EP | claimed |
| US-8148537-B2 | Substituted acetophenones useful as PDE4 inhibitors | LEO PHARMA A/S (DK) | 2012-04-03 | — | — | US | claimed |
| EP-2125736-B1 | SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS | LEO PHARMA AS (DK) | 2011-03-30 | — | — | EP | claimed |
| US-20100035908-A1 | SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS | LEO PHARMA (DK) | 2010-02-11 | — | — | US | claimed |
| CN-101611005-A | Be used as the acetophenones of the replacement of PDE4 inhibitor | LEO PHARMA AS (DK) | 2009-12-23 | — | — | CN | claimed |
| EP-2125736-A1 | SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS | Leo Pharma A/S (DK) | 2009-12-02 | — | — | EP | claimed |
| WO-2008077404-A1 | SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS | LEO PHARMA A/S (DK) | 2008-07-03 | — | — | WO | claimed |
| US-12534685-B2 | Fragrance composition | SYMRISE AG (DE) | 2026-01-27 | — | — | US | disclosed |
| EP-3752497-B1 | P300/CBP HAT INHIBITORS | CONSTELLATION PHARMACEUTICALS INC (US) | 2024-07-17 | — | — | EP | disclosed |
| CN-118251440-A | Copolymers derived from dicyclopentadiene | 高新特殊工程塑料全球技术有限公司 | 2024-06-25 | — | — | CN | disclosed |
| US-4172782-A | ORGANIC QUATERNARY AMMONIUM SALT USED IN ALKULATION OF BENZYLNITRILE WITH AN ORGANIC HALIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1979-10-30 | — | — | US | disclosed |
| US-4043634-A | Liquid crystal electro optical element | DAI NIPPON TORYO CO., LTD. (JA) | 1977-08-23 | — | — | US | disclosed |
| US-3977768-A | Nematic liquid crystal compositions | DAI NIPPON TORYO KAUBSHIKI KAISHA (JA) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12534685-B2 | Fragrance composition | NCLN, HCN2, TRPA1 | CYP2A6 3094/4885TSHR 3358/4885HSD17B10 1185/4885 |
| US-20100035908-A1 | SUBSTITUTED ACETOPHENONES USEFUL AS PDE4 INHIBITORS | PDE4A, PDE4B, PDE3B | CYP2A6 117/4885TSHR 2409/4885HSD17B10 131/4885 |
| US-20230159854-A1 | A FRAGRANCE COMPOSITION | NISCH, NOS1, COXFA4 | CYP2A6 1637/4885TSHR 4764/4885HSD17B10 790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.